FibroBiologics, Inc. (FBLG) stock
FBLGNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.90−0.02 (-2.56%)
Close on Nov 16, 2026Market cap $6.02MP/E –Yield –
FibroBiologics cash
Cash and short-term investments held at the end of each period.
FibroBiologics's cash was $3.52M at Jun 30, 2026. For fiscal 2025 it was $4.89M, down 65.0% from the year before. The highest annual figure on record is $13.99M in fiscal 2024.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.89M | -65.0% |
| FY2024 | Dec 31, 2024 | $13.99M | +52.6% |
| FY2023 | Dec 31, 2023 | $9.16M | +304.4% |
| FY2022 | Dec 31, 2022 | $2.27M | +456.8% |
| FY2021 | Dec 31, 2021 | $407.00K | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $3.52M | -60.3% |
| Q1 FY2026 | Mar 31, 2026 | $1.48M | -82.9% |
| Q4 FY2025 | Dec 31, 2025 | $4.89M | -65.0% |
| Q3 FY2025 | Sep 30, 2025 | $4.87M | -37.8% |
| Q2 FY2025 | Jun 30, 2025 | $8.85M | +48.1% |
| Q1 FY2025 | Mar 31, 2025 | $8.67M | +6.2% |
| Q4 FY2024 | Dec 31, 2024 | $13.99M | +52.6% |
| Q3 FY2024 | Sep 30, 2024 | $7.83M | -27.3% |
| Q2 FY2024 | Jun 30, 2024 | $5.97M | -47.5% |
| Q1 FY2024 | Mar 31, 2024 | $8.16M | -44.7% |
| Q4 FY2023 | Dec 31, 2023 | $9.16M | +304.4% |
| Q3 FY2023 | Sep 30, 2023 | $10.77M | +2545.2% |
| Q2 FY2023 | Jun 30, 2023 | $11.38M | – |
| Q1 FY2023 | Mar 31, 2023 | $14.74M | – |
| Q4 FY2022 | Dec 31, 2022 | $2.27M | – |
| Q4 FY2021 | Dec 31, 2021 | $407.00K | – |
See a number that looks wrong?